Interesting no talk on Nico from holders. Apparently share holders to be updated in relation to the latest institutional raise when news comes. The Victorian deal is now on their website. Still would probably prefer a US listing in the latter part of next year.
I'm also interested in this:
Nicolab is finalising a Memorandum of Understanding with a pre-eminent organisation in the digital health and AI-powered clinical decision space, to leverage their respective expertise and resources to deliver high-quality telehealth services for stroke care to patients in Australia, predominantly focussed on regional, remote and Indigenous communities.
Exciting news is this:
The final study results were outstanding, showing that our algorithm is highly accurate. These results form the basis of our FDA submission. We are on track to submit our Perfusion algorithm to the FDA by the end of the May 2023, in accordance with previously communicated timelines.
